Unraveling the Microscopic Mechanism of Molecular Ion Interaction with Monoclonal Antibodies: Impact on Protein Aggregation

Suman Saurabh,Qinkun Zhang,John M. Seddon,Jian R. Lu,Cavan Kalonia,Fernando Bresme
DOI: https://doi.org/10.1021/acs.molpharmaceut.3c00963
2024-02-12
Molecular Pharmaceutics
Abstract:Understanding and predicting protein aggregation represents one of the major challenges in accelerating the pharmaceutical development of protein therapeutics. In addition to maintaining the solution pH, buffers influence both monoclonal antibody (mAb) aggregation in solution and the aggregation mechanisms since the latter depend on the protein charge. Molecular-level insight is necessary to understand the relationship between the buffer-mAb interaction and mAb aggregation. Here, we use all-atom molecular dynamics simulations to investigate the interaction of phosphate (<i>Phos</i>) and citrate (<i>Cit</i>) buffer ions with the Fab and Fc domains of mAb COE3. We demonstrate that <i>Phos</i> and <i>Cit</i> ions feature binding mechanisms, with the protein that are very different from those reported previously for histidine <i>(His)</i>. These differences are reflected in distinctive ion-protein binding modes and adsorption/desorption kinetics of the buffer molecules from the mAb surface and result in dissimilar effects of these buffer species on mAb aggregation. While <i>His</i> shows significant affinity toward hydrophobic amino acids on the protein surface, <i>Phos</i> and <i>Cit</i> ions preferentially bind to charged amino acids. We also show that <i>Phos</i> and <i>Cit</i> anions provide bridging contacts between basic amino acids in neighboring proteins. The implications of such contacts and their connection to mAb aggregation in therapeutic formulations are discussed.
pharmacology & pharmacy,medicine, research & experimental
What problem does this paper attempt to address?